Evidence map›Paper›PMID 35680413›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Role of Prostate-Specific Membrane Antigen PET in Metastatic Prostate Cancer: We Have the Answers.

Kelsey L Pomykala, Ken Herrmann, Anwar R Padhani, Michael S Hofman, Elisabetta Lalumera, Stefano Fanti

Open access · bronzeAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 4 countries.

Kelsey L PomykalaInstitute for Artificial Intelligence in Medicine, University Hospital Essen, Essen, Germany; Kelsey.herrmann@uk-essen.de.
Ken HerrmannDepartment of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany.
Anwar R PadhaniPaul Strickland Scanner Centre, Mount Vernon Cancer Centre, Northwood, United Kingdom.
Michael S HofmanProstate Cancer Theranostics and Imaging Centre of Excellence, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.
Elisabetta LalumeraDepartment for Life Quality Studies, University of Bologna, Rimini, Italy.
Stefano FantiDepartment of Nuclear Medicine, Policlinico S. Orsola, University of Bologna, Bologna, Italy; and.
Essen University Hospital · DEIstituti di Ricovero e Cura a Carattere Scientifico · ITMount Vernon Cancer Centre · GBPeter MacCallum Cancer Centre · AUUniversity of Bologna · ITUniversity of Duisburg-Essen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ProstateProstatic NeoplasmsGallium RadioisotopesHumansMalePositron-Emission TomographyPositron Emission Tomography Computed TomographyProstate-Specific AntigenGallium RadioisotopesProstate-Specific Antigen

Identifiers

PMID35680413
PMCPMC9536712
OpenAlexW4282924402

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.